vs

Side-by-side financial comparison of biote Corp. (BTMD) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.

biote Corp. is the larger business by last-quarter revenue ($46.4M vs $38.5M, roughly 1.2× Orchid Island Capital, Inc.). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs 4.2%, a 264.5% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs -6.9%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs -0.4%).

biote Corp is a healthcare company specializing in personalized bioidentical hormone replacement therapy solutions for adult men and women. It operates primarily in the U.S. market, offering training programs for licensed healthcare providers, along with complementary wellness supplements and diagnostic services to support patient care outcomes.

Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.

BTMD vs ORC — Head-to-Head

Bigger by revenue
BTMD
BTMD
1.2× larger
BTMD
$46.4M
$38.5M
ORC
Growing faster (revenue YoY)
ORC
ORC
+379.5% gap
ORC
372.6%
-6.9%
BTMD
Higher net margin
ORC
ORC
264.5% more per $
ORC
268.7%
4.2%
BTMD
Faster 2-yr revenue CAGR
ORC
ORC
Annualised
ORC
301.6%
-0.4%
BTMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BTMD
BTMD
ORC
ORC
Revenue
$46.4M
$38.5M
Net Profit
$2.0M
$103.4M
Gross Margin
Operating Margin
14.7%
Net Margin
4.2%
268.7%
Revenue YoY
-6.9%
372.6%
Net Profit YoY
-47.2%
1764.9%
EPS (diluted)
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTMD
BTMD
ORC
ORC
Q4 25
$46.4M
$38.5M
Q3 25
$48.0M
$26.9M
Q2 25
$48.9M
$23.2M
Q1 25
$49.0M
$19.7M
Q4 24
$49.8M
Q3 24
$51.4M
$340.0K
Q2 24
$49.2M
$-697.0K
Q1 24
$46.8M
$-2.5M
Net Profit
BTMD
BTMD
ORC
ORC
Q4 25
$2.0M
$103.4M
Q3 25
$8.2M
$72.1M
Q2 25
$3.2M
$-33.6M
Q1 25
$13.7M
$17.1M
Q4 24
$3.7M
Q3 24
$10.7M
$17.3M
Q2 24
$-7.1M
$-5.0M
Q1 24
$-4.2M
$19.8M
Operating Margin
BTMD
BTMD
ORC
ORC
Q4 25
14.7%
Q3 25
17.2%
Q2 25
22.0%
Q1 25
19.8%
Q4 24
5.6%
Q3 24
23.7%
Q2 24
12.7%
Q1 24
22.3%
Net Margin
BTMD
BTMD
ORC
ORC
Q4 25
4.2%
268.7%
Q3 25
17.1%
267.8%
Q2 25
6.5%
-145.0%
Q1 25
28.0%
86.9%
Q4 24
7.4%
Q3 24
20.8%
5094.1%
Q2 24
-14.4%
714.3%
Q1 24
-8.9%
-794.2%
EPS (diluted)
BTMD
BTMD
ORC
ORC
Q4 25
$0.05
Q3 25
$0.22
Q2 25
$0.10
Q1 25
$0.37
Q4 24
$0.09
Q3 24
$0.33
Q2 24
$-0.21
Q1 24
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTMD
BTMD
ORC
ORC
Cash + ST InvestmentsLiquidity on hand
$24.1M
$665.9M
Total DebtLower is stronger
$103.1M
Stockholders' EquityBook value
$-58.5M
$1.4B
Total Assets
$107.6M
$11.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTMD
BTMD
ORC
ORC
Q4 25
$24.1M
$665.9M
Q3 25
$28.0M
$583.9M
Q2 25
$19.6M
$440.8M
Q1 25
$41.7M
$396.4M
Q4 24
$39.3M
Q3 24
$38.2M
$322.1M
Q2 24
$26.4M
$241.0M
Q1 24
$78.8M
$190.4M
Total Debt
BTMD
BTMD
ORC
ORC
Q4 25
$103.1M
Q3 25
$104.7M
Q2 25
$106.3M
Q1 25
$107.8M
Q4 24
$109.4M
Q3 24
$110.9M
Q2 24
$112.5M
Q1 24
$114.1M
Stockholders' Equity
BTMD
BTMD
ORC
ORC
Q4 25
$-58.5M
$1.4B
Q3 25
$-72.8M
$1.1B
Q2 25
$-85.1M
$912.0M
Q1 25
$-90.0M
$855.9M
Q4 24
$-105.9M
Q3 24
$-130.3M
$656.0M
Q2 24
$-143.2M
$555.9M
Q1 24
$-36.0M
$481.6M
Total Assets
BTMD
BTMD
ORC
ORC
Q4 25
$107.6M
$11.7B
Q3 25
$111.3M
$9.1B
Q2 25
$104.8M
$7.6B
Q1 25
$123.4M
$7.3B
Q4 24
$122.4M
Q3 24
$101.3M
$5.9B
Q2 24
$92.9M
$4.9B
Q1 24
$160.1M
$4.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTMD
BTMD
ORC
ORC
Operating Cash FlowLast quarter
$7.6M
$120.4M
Free Cash FlowOCF − Capex
$6.5M
FCF MarginFCF / Revenue
14.0%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
3.87×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$30.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTMD
BTMD
ORC
ORC
Q4 25
$7.6M
$120.4M
Q3 25
$14.1M
$28.0M
Q2 25
$7.1M
$18.4M
Q1 25
$6.5M
$25.8M
Q4 24
$12.4M
Q3 24
$15.6M
$-14.8M
Q2 24
$9.9M
$19.3M
Q1 24
$7.4M
$45.0M
Free Cash Flow
BTMD
BTMD
ORC
ORC
Q4 25
$6.5M
Q3 25
$13.6M
Q2 25
$5.3M
Q1 25
$4.8M
Q4 24
$10.7M
Q3 24
$14.0M
Q2 24
$7.4M
Q1 24
$6.7M
FCF Margin
BTMD
BTMD
ORC
ORC
Q4 25
14.0%
Q3 25
28.3%
Q2 25
10.8%
Q1 25
9.9%
Q4 24
21.5%
Q3 24
27.3%
Q2 24
15.1%
Q1 24
14.2%
Capex Intensity
BTMD
BTMD
ORC
ORC
Q4 25
2.3%
Q3 25
1.0%
Q2 25
3.7%
Q1 25
3.3%
Q4 24
3.4%
Q3 24
3.0%
Q2 24
5.1%
Q1 24
1.5%
Cash Conversion
BTMD
BTMD
ORC
ORC
Q4 25
3.87×
1.16×
Q3 25
1.72×
0.39×
Q2 25
2.22×
Q1 25
0.47×
1.51×
Q4 24
3.34×
Q3 24
1.45×
-0.86×
Q2 24
Q1 24
2.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTMD
BTMD

Product Revenue$45.3M98%
Disposable Trocars Product Revenue$1.2M3%

ORC
ORC

Segment breakdown not available.

Related Comparisons